BrainStorm Cell Therapeutics Inc. (BCLI) stock
BCLIOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.77−0.01 (-1.17%)
Close on Oct 19, 2026Market cap $8.50MP/E –Yield –
BrainStorm Cell Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
BrainStorm Cell Therapeutics's enterprise value was $9.74M on Oct 19, 2026, against $5.65M a year earlier. Over the last 5 years it ranged from $4.99M to $149.02M, with a median of $14.67M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $9.74M | +57.1% |
| 2025 | Dec 31, 2025 | $6.20M | -47.0% |
| 2024 | Dec 31, 2024 | $11.70M | +8.2% |
| 2023 | Dec 29, 2023 | $10.82M | -79.4% |
| 2022 | Dec 30, 2022 | $52.54M | -55.2% |
| 2021 | Dec 31, 2021 | $117.30M | +2.7% |
| 2020 | Dec 31, 2020 | $114.19M | +20.7% |
| 2019 | Dec 31, 2019 | $94.63M | +51.2% |
| 2018 | Dec 31, 2018 | $62.60M | -1.1% |
| 2017 | Dec 29, 2017 | $63.32M | +74.5% |
| 2016 | Dec 30, 2016 | $36.27M | +1.6% |
| 2015 | Dec 31, 2015 | $35.70M | -42.3% |
| 2014 | Dec 31, 2014 | $61.92M | +132.7% |
| 2013 | Dec 31, 2013 | $26.61M | -5.8% |
| 2012 | Dec 31, 2012 | $28.24M | +17.7% |
| 2011 | Dec 30, 2011 | $23.99M | – |
See a number that looks wrong?